Furosemide Injection, Solution
Product Images NDC 51662-1719

5 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 51662-1719). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (51662 1719 Structure)

Structure (51662 1719 Structure)
Chemical structure of furosemide, showing a benzene ring with attached functional groups including sulfonamide, chlorine, carboxyl, and a furan ring connected via an amine linkage.*
FDA Label Image

Vial (51662 1719 1 Vial Label)

Vial (51662 1719 1 Vial Label)
A small white adhesive label with black text and a QR code, showing product information for FUROSEMIDE injection, solution. The label includes identifiers such as GTIN (00351662171912), expiration date (300919), and lot number (789210). It indicates the product is distributed by HF Acquisition Co., LLC in Mukilteo, WA, with the note 'SEE MANUFACTURER'S INSERT' and 'RX ONLY' on the side.*
FDA Label Image

Vial (Vial Label 31722 310 31 Furosemide Injection Usp 40mg Per 4ml (10mg Per mL) 4ml Vial)

Vial (Vial Label 31722 310 31 Furosemide Injection  Usp 40mg Per 4ml (10mg Per mL) 4ml Vial)
Label for Furosemide Injection, USP 10 mg/mL (40 mg/4 mL) single-dose vial by Camber Pharmaceuticals, Inc. The label indicates use for intravenous or intramuscular administration and includes lot and expiration placeholders, a barcode, and manufacturer details including Aspiro Pharma Limited in India.*
FDA Label Image

Pouch (51662 1719 2 Pouch)

Pouch (51662 1719 2 Pouch)
Label of FUROSEMIDE injection, USP 40 mg/4 mL (10 mg/mL), 4 mL vial. The label shows the NDC number 51662-1719-2, lot number 789210, and expiration date 2030-09-19. It indicates intravenous or intramuscular use and includes storage instructions and manufacturer details for HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

Box (51662 1719 3 Box)

Box (51662 1719 3 Box)
Label for FUROSEMIDE injection, USP 40 mg per 4 mL vial (10 mg/mL) in a case of 25. It is for intravenous or intramuscular use and lists the lot number, expiration date, and ingredients. Distributed by HF Acquisition Co LLC, Mukilteo, WA. Contains storage instructions and a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.